REM sleep behavior disorder predisposed by neuroleptic malignant syndrome: a case report
- 27 Downloads
A 44-year-old man was confirmed by polysomnography to have rapid eye movement (REM) sleep behavior disorder (RBD) following recovery from haloperidol- and risperidone-induced neuroleptic malignant syndrome (NMS). RBD symptoms persisted for 30 days. Subsequently, no clinical symptoms or polysomnographic findings of RBD have been observed for 3 years. RBD is reported to be associated with Parkinson’s disease and dementia with Lewy bodies, which involve brainstem dopaminergic hypofunction. However, no reports have documented RBD due to drug-induced dopaminergic hypofunction. This appears to be the first observation of RBD in relation to pharmacological dopaminergic dysfunction.
KeywordsREM sleep behavior disorder REM sleep without muscle atonia Neuroleptic malignant syndrome
Compliance with ethical standards
Conflict of interest
The authors declare that they had no conflict of interest.
- 1.REM sleep behavior disorder. American Academy of Sleep Medicine. International Classification of Sleep Disorders, Third Edition. Darien: American Academy of Sleep Medicine; 2014. pp. 246–253.Google Scholar
- 8.Perry PJ, Wilborn CA. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Ann Clin Psychiatry. 2012;24(2):155–62.Google Scholar